Phase I biotransformation or functionalization entails the chemical transformation of drugs into metabolites via oxidative, reductive, and or hydrolytic …
Phase I biotransformation primarily involves microsomal enzymes that catalyze oxidative reactions, using molecular oxygen and NADPH. Notably, only one …
Reductive reactions introduce electrons to drug molecules, affecting polar functional groups like hydroxy and amino, allowing subsequent biotransformation …
Hydrolysis is a chemical process where a compound is decomposed by reacting with water without altering its oxidation state.
This process plays a vital …
Conjugation involves the covalent linkage of a conjugating reagent to drugs or their metabolites in the presence of a transferase enzyme.
These reagents …
Glucuronidation, a key phase II biotransformation reaction, involves the conjugation of glucuronic acid to xenobiotics or metabolites.
This process is …
Sulfation, a phase II biotransformation reaction, involves the addition of a polar sulfate group to a drug.
The process is catalyzed by nonmicrosomal …
Drug metabolism varies among species due to distinct enzyme systems and metabolic pathways.
Even within the same species, diverse strains can exhibit …
The liver has numerous functions, including nutrient metabolism. In contrast to other in vitro and in vivo models of liver research, the isolated perfused …
A lack of validated cancer models that recapitulate the tumor microenvironment of solid cancers in vitro remains a significant bottleneck for preclinical …
Finding a long-term, human-relevant culture model for primary human hepatocytes (PHHs) for pharmacological and toxicological studies remains a challenge. …